Teva Pharmaceutical Industries (MEX:TEVA N) Inventories, Work In Process: MXN6,961 Mil (As of Mar. 2026)


MEX:TEVA N Teva Pharmaceutical Industries Ltd MEX:TEVA N
40 GF Score
Price MXN597.50
GF Value MXN347.38
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Teva Pharmaceutical Industries Inventories, Work In Process?

Teva Pharmaceutical Industries MEX:TEVA N 40 Inventories, Work In Process is MXN6,961 Mil as of Mar. 2026. GuruFocus rates MEX:TEVA N with a GF Score™ of 40/100 and a GF Value™ of MXN347.38 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Teva Pharmaceutical Industries's work in process for the quarter that ended in Mar. 2026 was MXN6,961 Mil.

Teva Pharmaceutical Industries Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for Teva Pharmaceutical Industries's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Teva Pharmaceutical Industries Inventories, Work In Process Chart

Teva Pharmaceutical Industries Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Work In Process
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12,041.72 10,820.28 8,487.12 7,362.06 6,554.08

Teva Pharmaceutical Industries Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,712.74 7,381.05 6,053.59 6,554.08 6,960.62
MEX:TEVA N
40GF Score
Teva Pharmaceutical Industries Ltd MEX:TEVA N
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Teva Pharmaceutical Industries Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of MXN6,961 Mil mean?
Teva Pharmaceutical Industries (MEX:TEVA N) has a Inventories, Work In Process of MXN6,961 Mil as of Mar. 2026. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Teva Pharmaceutical Industries and its competitors.
Is Teva Pharmaceutical Industries' Inventories, Work In Process too high?
Teva Pharmaceutical Industries' current Inventories, Work In Process is MXN6,961 Mil. Overall, Teva Pharmaceutical Industries has a GF Score™ of 40/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Teva Pharmaceutical Industries' Inventories, Work In Process compare to ZTS and UTHR?
Teva Pharmaceutical Industries' Inventories, Work In Process of MXN6,961 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Drug Manufacturers company?
A good Inventories, Work In Process depends on the Drug Manufacturers industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Teva Pharmaceutical Industries and its competitors. Teva Pharmaceutical Industries's current Inventories, Work In Process is MXN6,961 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teva Pharmaceutical Industries stock overvalued right now?
Based on GuruFocus' analysis, Teva Pharmaceutical Industries (MEX:TEVA N) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN347.38, compared to a current price of MXN597.50 — trading 72% above its estimated fair value. The current Inventories, Work In Process is MXN6,961 Mil. Teva Pharmaceutical Industries' overall GF Score™ is 40/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For Teva Pharmaceutical Industries (MEX:TEVA N), the current Inventories, Work In Process is MXN6,961 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Teva Pharmaceutical Industries (MEX:TEVA N) Overvalued in 2026?

Based on GuruFocus' analysis, Teva Pharmaceutical Industries stock appears to be overvalued. The current stock price of MXN597.50 is trading 72% above its estimated GF Value™ of MXN347.38. GuruFocus considers Teva Pharmaceutical Industries to be Significantly Overvalued.

Key valuation signals for MEX:TEVA N:

  • Inventories, Work In Process: MXN6,961 Mil
  • GF Value™: MXN347.38 vs. price of MXN597.50 (72% above fair value)
  • GF Score™: 40/100 with 5 warning signs

No single metric tells the full story. See the MEX:TEVA N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Teva Pharmaceutical Industries Business Description

Address 124 Dvora HaNevi’a Street, Tel Aviv, ISR, 6944020
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
40GF Score

Get the complete analysis for MEX:TEVA N

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN597.50
Price
MXN347.38
GF Value